CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - CAD ($) |
Total |
Share Purchase Agreement |
At-the-market agreement |
Public Offering |
Share Capital |
Share Capital
Share Purchase Agreement
|
Share Capital
At-the-market agreement
|
Share Capital
Public Offering
|
Warrants |
Contributed Surplus |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity balance at beginning of period at Dec. 31, 2018 | $ 6,195,363 | $ 285,193,061 | $ 3,617,570 | $ 28,260,613 | $ 607,504 | $ (311,483,385) | ||||||
| Net loss and other comprehensive income | (33,266,291) | (143,403) | (33,122,888) | |||||||||
| Issued pursuant to incentive share award plan (note 10) | 0 | 391,917 | (391,917) | |||||||||
| Issued | $ 5,403,385 | $ 8,476,454 | $ 3,314,429 | $ 5,403,385 | $ 8,476,454 | $ 3,314,429 | ||||||
| Issued pursuant to warrant derivative exercised (note 8, 9) | 9,152,869 | 9,152,869 | ||||||||||
| Share-based compensation (note 10) | 1,470,153 | 1,470,153 | ||||||||||
| Share issue costs (note 9) | (854,256) | (854,256) | ||||||||||
| Equity balance at end of period at Dec. 31, 2019 | (107,894) | 311,077,859 | 3,617,570 | 29,338,849 | 464,101 | (344,606,273) | ||||||
| Net loss and other comprehensive income | (22,568,933) | (63,876) | (22,505,057) | |||||||||
| Issued pursuant to stock option plan (note 10) | 241,922 | 385,022 | (143,100) | |||||||||
| Issued pursuant to incentive share award plan (note 10) | 0 | 732,367 | (732,367) | |||||||||
| Issued | 40,037,786 | 40,037,786 | ||||||||||
| Issued pursuant to warrant derivative exercised (note 8, 9) | 6,332,778 | 6,332,778 | ||||||||||
| Share-based compensation (note 10) | 2,558,974 | 2,558,974 | ||||||||||
| Share issue costs (note 9) | (1,741,640) | (1,741,640) | ||||||||||
| Equity balance at end of period at Dec. 31, 2020 | 24,752,993 | 356,824,172 | 3,617,570 | 31,022,356 | 400,225 | (367,111,330) | ||||||
| Net loss and other comprehensive income | (26,316,766) | (12,487) | (26,304,279) | |||||||||
| Issued pursuant to stock option plan (note 10) | 238,450 | 381,771 | (143,321) | |||||||||
| Issued pursuant to incentive share award plan (note 10) | 0 | 543,833 | (543,833) | |||||||||
| Issued | $ 34,168,071 | $ 34,168,071 | ||||||||||
| Issued pursuant to warrant derivative exercised (note 8, 9) | 686,616 | 686,616 | ||||||||||
| Share-based compensation (note 10) | 3,825,901 | 3,825,901 | ||||||||||
| Share issue costs (note 9) | (1,256,280) | (1,256,280) | ||||||||||
| Equity balance at end of period at Dec. 31, 2021 | $ 36,098,985 | $ 391,348,183 | $ 3,617,570 | $ 34,161,103 | $ 387,738 | $ (393,415,609) |